Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Best Pract Res Clin Haematol. 2008 Jun;21(2):205–222. doi: 10.1016/j.beha.2008.02.007

Table 1.

Indications for donor leukocyte infusion (DLI).

To treat relapsed disease after stem-cell transplantation (SCT)
Prophylactic DLI to prevent relapse and viral reactivation:
     T-cell-depleted grafts
     Non-myeloablative SCT
     Advanced disease stage
Induce full donor chimerism
Enhance immune reconstitution
Treat viral infection after SCT
Treat post-transplant lymphoproliferative disorder (PTLD)